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Abstract
Background: Familial Mediterranean fever (FMF) is a disorder characterized by recurrent attacks of fever and serosal
inflammation, particularly abdominal pain. Other disease processes, including medical and surgical emergencies, may
mimic FMF, especially in atypical cases.
Case Presentation: We present a case of an adolescent male, referred to us with a diagnosis of colchicine resistant
FMF, ultimately diagnosed with intestinal malrotation and recurrent volvulus.
Conclusions: In atypical presentations of FMF with potential “red flags”, a thorough patient history is extremely
important and should result in prompt referral for the appropriate diagnostic tests.
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Background
Familial Mediterranean Fever (FMF), the most common
monogenic autoinflammatory syndrome, is characterized by
recurrent episodes of fever and serosal inflammation, includ-
ing abdominal pain and vomiting. Intestinal malrotation
which occurs as a result of an arrest of normal rotation of
the embryonic gut, has a varied clinical presentation from in-
fancy through adolescence and adulthood [1, 2]. We present
a case of an adolescent male, referred to us with recurrent
vomiting and abdominal pain, initially diagnosed with FMF
that was resistant to colchicine, ultimately diagnosed with in-
testinal malrotation.
Case presentation
A 14 year old male of mixed Sephardic-Ashkenazi Jewish
ancestry was referred to our Pediatric Rheumatology
Clinic with “colchicine resistant FMF”. From early infancy
he suffered from recurrent afebrile episodes of yellowish-
greenish vomiting with abdominal pain. Episodes occurred
every 1 to 2 weeks, lasting for 1–3 days. Exercise, stress
and infections were precipitants of episodes. The patient
did not develop rashes, joint/muscle or chest pain. He was
hospitalized during several episodes due to dehydration,
easily corrected by intravenous fluids. His school attend-
ance was severely impaired, missing about 2 days every
week. His father was diagnosed with FMF, after years of
recurrent fever, abdominal pain and vomiting, with com-
pound heterozygous mutations on the MEFV gene
(M694V/E148Q). Following father’s diagnosis, our patient
underwent genetic analysis at age 11 years and a heterozy-
gote E148Q mutation was found. Colchicine was initiated
and he received up to 1.5 mg/d for 2 years prior to his
referral, with no clinical improvement. He underwent
investigations by multiple pediatric gastroenterologists
and metabolic diseases specialists, and his laboratory
evaluation was normal including: acute phase reac-
tants (even during episodes), blood counts, liver and
muscle enzymes, fibrinogen, celiac profile, amino-acids,
organic acids, acyl-carnitine and E3 mutation. Abdominal
radiographs and ultrasound were normal. His physical
examination was unremarkable except for low weight (7th
percentile). Due to the history of bilious vomiting since
his neonatal period he was referred by us for an upper
gastrointestinal series (UGI). This demonstrated mal-
position of the ligament of Treitz and a corkscrew
appearance of the duodenum, consistent with malrotation
(Fig. 1). After a successful Ladd procedure with classical
findings of malrotation but no intestinal ischemia,
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the patient is feeling well, with no further vomiting epi-
sodes, a rapid catch up in the growth curves and full
school attendance.
Discussion and conclusion
We present a patient with intestinal malrotation who
was initially diagnosed with FMF and treated for 2 years
with an adequate dose of colchicine with no response.
Fortunately, he did not develop bowel damage after
years of recurrent attacks of midgut volvulus.
While the patient fulfilled clinical diagnostic criteria
for FMF (Table 1) according to the long-(but not short)
version of the Tel-Hashomer criteria [3] (one minor and
six supportive criteria), and the Yalcinkaya pediatric
criteria [4], several “red-flags” led us to consider an
alternative diagnosis.
1. Neonatal onset of FMF is uncommon [5–7].
About 31 % percent of patients with FMF present
by age 2 years (mean 1.1 years) [8], 80 % by
10 years and 90 % by 20 years, but only about
5 % by 2 months of age. The most common
presentation in the infants is just “fussiness”. In
almost all others fever is part of the presentation
[7, 8], thus isolated vomiting in patients under
1 year of age is very uncommon.
2. Bilious vomiting is not characteristic in FMF.
3. The lack of fever and other symptoms characteristic
of FMF. These would be expected in a patient with
Fig. 1 Upper gastrointestinal study (UGI) demonstrating intestinal
malrotation and volvulus with abnormal position of the duodenal-jejunal
junction to the right of the spine. Normally the duodenum should
sweep across from right to left across the spine (dashed line shows
the left spinal pedicles). A corkscrew appearance of the duodenum
(arrow) demonstrates the volvulus
Table 1 Clinical diagnostic criteria for familial Mediterranean
fever (FMF)




Typical attacks (≥3 of the same type, rectal temp ≥38 °C, attacks lasting
12 h to 3 days)
1.Peritonitis
2.Pleuritis (unilateral) or pericarditis
3.Monoarthritis (hip, knee, ankle)
4.Fever alone
Minor Criteria
1. Incomplete attacks (typical attacks including one of the following
sites: abdomen, chest or joint with 1 or 2 of the following exceptions:
1) Temperature < 38 °C, 2) attacks lasting 6–12 h or 3–7 days, 3) no
signs of peritonitis during abdominal attacks, 4) localized abdominal
pain, 5) arthritis in joints other than hip, knee or ankle)
2. Exertional leg pain
3. Favorable response to colchicine
Supportive Criteria
1. Family history of FMF
2. Appropriate ethnic origin
3. Age <20 year at disease onset
4–7 are related to features of attacks:
4. Severe, requiring bed rest
5. Spontaneous remission
6. Symptom-free interval
7. Transient inflammatory response with one or more abnormal test
result(s) for white blood cell count, erythrocyte sedimentation rate,
serum amyloid A, and /or fibrinogen
8. Episodic proteinuria/hematuria
9. Unproductive laparotomy or removal of “white” appendix
10. Consanguinity of parents
An FMF diagnosis requires ≥1 major criteria, or ≥2 minor criteria, or
1 minor criteria plus ≥5 supportive criteria, or 1 minor criteria plus ≥4
of the first 5 supportive criteria.
Short Version
Major criteria
1.Recurrent febrile attacks accompanied by peritonitis, synovitis or pleuritis.
2.Amyloidosis of the AA-type without predisposing disease.
3.Favorable response to continuous colchicine treatment.
Minor criteria
4. Recurrent febrile attacks
5. Erysipelas-like erythema
6. FMF in a first degree relative
Definitive diagnosis: 2 major or 1 major and 2 minor.
Probable diagnosis: 1 major and 1 minor
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severe FMF based on the frequency of attacks, age
of onset and lack of response to colchicine [6, 9].
4. Normal acute phase reactants during attacks.
Besides clinical criteria, the diagnosis of our patient
and treatment with colchicine was initially supported by
finding a heterozygous E148Q mutation on the MEFV
gene. Genetic testing in FMF is only considered support-
ive and not diagnostic, particularly in atypical cases.
When two mutations are found, FMF diagnosis is
confirmed. In atypical cases where only one mutation is
found a trial of colchicine is often offered. Indeed up to
30 % of FMF have only a heterozygote exon ten muta-
tion [10]. However, controversy exists regarding the role
of some MEFV variations (Table 2), particularly for the
exon 2 E148Q glutamic acid to glutamine substitution
[11]. Initially, this sequence variation was described as a
disease causing mutation with low penetrance and mild
symptoms. However, recent studies showed a similar
frequency of E148Q among FMF patients and controls,
and those findings support the hypothesis that E148Q is
a benign polymorphism and not a disease causing muta-
tion [12–14]. E148Q may be a disease modifier in other
rheumatologic conditions [15–17]. E148Q may also
modify the severity of FMF when found on the same
allele with other mutations. FMF patients who are
homozygous for the complex allele (E148Q-V726A/
E148Q-V726A), or compound heterozygotes (E148Q-
V726A/V726A), have a more severe disease compared to
patients homozygous for V726A [14]. In our patient the
E148Q substitution is likely to be only a polymorphism,
unlike his father who had a compound heterozygote
M694V/E148Q mutation.
Multiple other disease processes may closely resemble
FMF and must be excluded in atypical cases, such as
surgical emergencies, metabolic diseases and other
periodic fever syndromes (Table 3) [18, 19]. Both FMF
diagnostic criteria have excellent but not 100 % specifi-
city for the population in whom it was developed (99 %
for adults with the Tel-Hashomer criteria [3], 92 % for
children with the Yalcinkaya criteria [4]). However, the
Tel-Hashomer criteria developed for adults had a lower
specificity (54 %) in children [4]. Therefore, in atypical
cases with potential “red flags” a thorough patient
history is extremely important and should result in
prompt referral for the appropriate diagnostic tests.
Malrotation is an incomplete rotation of the intestine
during fetal development. The mesentery, including the
Table 1 Clinical diagnostic criteria for familial Mediterranean
fever (FMF) (Continued)
Yalçinkaya Pediatric Criteria (adapted from reference #4: Yalçinkaya F, et al.
Rheumatology (Oxford, England) 2009;48:395–8)
Criteria Description
Fever Axillary temperature of >38 °C, 6–72 h of
duration, ≥3 attacks
Abdominal pain 6–72 h of duration, ≥3 attacks
Chest pain 6–72 h of duration, ≥3 attacks
Arthritis 6–72 h of duration, ≥3 attacks, oligoarthritis
Family history of FMF
Two of five criteria diagnose FMF
Table 2 Clinical significance of the common mutations/variations
found in the MEFV gene









Mutations usually associated with atypical FMF





aCan be associated with disease in compound heterozygote with
other mutations
Table 3 Differential diagnosis of recurrent vomiting (often with
abdominal pain) other than familial Mediterranean fever (FMF)






Dietary protein intolerance PUD PUD
Metabolic disorderb Pancreatitis Cyclic vomiting
Renal disorder/obstruction Cyclic vomiting Pancreatitis






aIncludes malrotation with midgut volvulus, pyloric stenosis, intussusception,
Hirschsprung disease, congenital atresia/stenosis/webs, incarcerated hernia
bIncludes urea cycle defects, organic acidemias, fatty acid oxidation defects,
disorders of gluconeogenesis in infancy, and porphyria in childhood/adolescence
GERD gastroesophageal reflux, IBD inflammatory bowel disease, PUD peptic
ulcer disease
The common causes in each age are marked in bold. Functional
gastrointestinal disorders are a common cause of recurrent abdominal pain
but without vomiting
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superior mesenteric artery, is tethered by a narrow stalk,
which can twist around itself, and produce life threaten-
ing midgut volvulus, with an acute presentation of small
bowel obstruction. Traditionally, intestinal malrotation
is considered primarily a disease of infancy with infre-
quent occurrence beyond the first year of life. However,
recent studies demonstrate that the prevalence of
malrotation in older children and adults appears to be
higher than previously thought [1, 2]. Upper gastro-
intestinal series is the gold standard imaging test for
diagnosis. Surgical intervention is recommended re-
gardless of age, and presentation of volvulus requires
an emergency procedure.
In summary, alterative diagnoses to FMF should be
considered in cases of atypical attacks as in our patient,
even if fulfilling diagnostic criteria and supported
partially by a heterozygous mutation in the MEFV gene.
In some cases, as we described, the correct diagnosis
may represent a surgical or medical emergency requir-
ing prompt treatment.
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